Ati cautat: sindrom inflamator copii
OMS studiaza posibila legatura dintre Covid-19 si maladia Kawasaki
Protocol terapeutic: L01XX24 – DCI PEGASPARGASUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: H05AA03 – DCI PARATHYROID HORMONE (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB03 – DCI AGALSIDASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N04BC07 – DCI APOMORFINUM (actualizat MARTIE 2022 conform ordin MS/CNAS NR 702/133/2022)
Noi reglementari privind prescriptiile medicale electronice pentru medicamente
Primul caz de boala Kawasaki asociata Covid-19 la un copil din Romania
Protocol terapeutic: L01XC16 – DCI DINUTUXIMAB BETA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB12 – DCI ELOSULFASE ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AC11 – DCI SILTUXIMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
